• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

苏丹乳腺癌女性中BRCA2基因单等位基因携带特征性杂合L1053X突变。

Monoallelic characteristic-bearing heterozygous L1053X in BRCA2 gene among Sudanese women with breast cancer.

作者信息

Elimam Alsmawal A, Aabdein Mohamed Elmogtba Mouaweia Mohamed, Eldeen Mohamed El-Fatih Moly, Altayb Hisham N, Taha Mohamed Adel, Nimir Mohammed N, Dafaalla Mohamed D, Alfaki Musaab M, Abdelrahim Mohamed A, Abdalla Abdelmohaymin A, Mohammed Musab I, Ellaithi Mona, Hamid Muzamil Mahdi Abdel, Hassan Mohamed Ahmed Salih

机构信息

Post-graduate College, Al-Neelain University, Khartoum, Sudan.

Daoud Research Group, Khartoum, Sudan.

出版信息

BMC Med Genet. 2017 Aug 16;18(1):85. doi: 10.1186/s12881-017-0448-x.

DOI:10.1186/s12881-017-0448-x
PMID:28814288
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5559773/
Abstract

BACKGROUND

Breast cancer (BC) is the most common type of cancer in women. Among many risk factors of BC, mutations in BRCA2 gene were found to be the primary cause in 5-10% of cases. The majority of deleterious mutations are frameshift or nonsense mutations. Most of the reported BRCA2 mutations are protein truncating mutations.

METHODS

The study aimed to describe the pattern of mutations including single nucleotide polymorphisms (SNPs) and variants of the BRCA2 (exon11) gene among Sudanese women patients diagnosed with BC. In this study a specific region of BRCA2 exon 11 was targeted using PCR and DNA sequencing.

RESULTS

Early onset cases 25/45 (55.6%) were premenopausal women with a mean age of 36.6 years. Multiparity was more frequent within the study amounting to 30 cases (66.6%), with a mean parity of 4.1. Ductal type tumor was the predominant type detected in 22 cases (48.8%) among the reported histotypes. A heterozygous monoallelic nonsense mutation at nucleotide 3385 was found in four patients out of 9, where TTA codon was converted into the stop codon TGA.

CONCLUSION

This study detected a monoallelic nonsense mutation in four Sudanese female patients diagnosed with early onset BC from different families. Further work is needed to demonstrate its usefulness in screening of BC.

摘要

背景

乳腺癌(BC)是女性中最常见的癌症类型。在BC的众多风险因素中,发现BRCA2基因突变是5%-10%病例的主要病因。大多数有害突变是移码突变或无义突变。大多数报道的BRCA2突变是蛋白质截短突变。

方法

本研究旨在描述苏丹女性乳腺癌患者中BRCA2(外显子11)基因的突变模式,包括单核苷酸多态性(SNP)和变异。在本研究中,使用聚合酶链反应(PCR)和DNA测序靶向BRCA2外显子11的特定区域。

结果

25/45例(55.6%)早发病例为绝经前女性,平均年龄36.6岁。多产在研究对象中更为常见,共30例(66.6%),平均产次为4.1。在报告的组织学类型中,导管型肿瘤是最主要的类型,有22例(48.8%)。在9例患者中的4例中发现了核苷酸3385处的杂合单等位无义突变,其中TTA密码子转换为终止密码子TGA。

结论

本研究在4例来自不同家庭、被诊断为早发性BC的苏丹女性患者中检测到单等位无义突变。需要进一步开展工作以证明其在BC筛查中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3001/5559773/75dec21f911f/12881_2017_448_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3001/5559773/a565f9fd9c2b/12881_2017_448_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3001/5559773/d6d4d70117f6/12881_2017_448_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3001/5559773/75dec21f911f/12881_2017_448_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3001/5559773/a565f9fd9c2b/12881_2017_448_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3001/5559773/d6d4d70117f6/12881_2017_448_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3001/5559773/75dec21f911f/12881_2017_448_Fig3_HTML.jpg

相似文献

1
Monoallelic characteristic-bearing heterozygous L1053X in BRCA2 gene among Sudanese women with breast cancer.苏丹乳腺癌女性中BRCA2基因单等位基因携带特征性杂合L1053X突变。
BMC Med Genet. 2017 Aug 16;18(1):85. doi: 10.1186/s12881-017-0448-x.
2
Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India.印度乳腺癌患者中乳腺癌易感基因BRCA1、BRCA2和p53基因的新型种系突变。
Breast Cancer Res Treat. 2004 Nov;88(2):177-86. doi: 10.1007/s10549-004-0593-8.
3
Reevaluation of the BRCA2 truncating allele c.9976A > T (p.Lys3326Ter) in a familial breast cancer context.在家族性乳腺癌背景下对BRCA2截短等位基因c.9976A > T(p.Lys3326Ter)的重新评估。
Sci Rep. 2015 Oct 12;5:14800. doi: 10.1038/srep14800.
4
BRCA2 germline mutations in Cypriot patients with familial breast/ovarian cancer.塞浦路斯家族性乳腺癌/卵巢癌患者中的BRCA2种系突变
Hum Mutat. 2003 Feb;21(2):171. doi: 10.1002/humu.9110.
5
Minor role for BRCA2 (exon11) and p53 (exon 5-9) among Sudanese breast cancer patients.在苏丹乳腺癌患者中,BRCA2(第11外显子)和p53(第5 - 9外显子)的作用较小。
Breast Cancer Res Treat. 2002 Jan;71(2):145-7. doi: 10.1023/a:1013807830329.
6
Germline TP53 mutation spectrum in Sudanese premenopausal breast cancer patients: correlations with reproductive factors.苏丹绝经前乳腺癌患者种系 TP53 突变谱:与生殖因素的相关性。
Breast Cancer Res Treat. 2019 Jun;175(2):479-485. doi: 10.1007/s10549-019-05168-1. Epub 2019 Feb 22.
7
Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families.49个位点特异性乳腺癌家族中BRCA2基因的突变分析。
Nat Genet. 1996 May;13(1):120-2. doi: 10.1038/ng0596-120.
8
Mutational analysis of the BRCA2 gene in breast carcinoma patients of Kashmiri descent.克什米尔血统乳腺癌患者中BRCA2基因的突变分析。
Mol Med Rep. 2014 Feb;9(2):749-53. doi: 10.3892/mmr.2013.1862. Epub 2013 Dec 13.
9
BRCA1 and BRCA2 status in a Central Sudanese series of breast cancer patients: interactions with genetic, ethnic and reproductive factors.苏丹中部一系列乳腺癌患者的BRCA1和BRCA2状态:与遗传、种族和生殖因素的相互作用
Breast Cancer Res Treat. 2007 Apr;102(2):189-99. doi: 10.1007/s10549-006-9303-z. Epub 2007 Mar 1.
10
Novel germline BRCA1 and BRCA2 mutations in Turkish women with breast and/or ovarian cancer and their relatives.患有乳腺癌和/或卵巢癌的土耳其女性及其亲属中的新型种系BRCA1和BRCA2突变
Cancer Invest. 2006 Aug-Sep;24(5):484-91. doi: 10.1080/07357900600814706.

引用本文的文献

1
Bioinformatics in Sudan: Status and challenges case study: The National University-Sudan.苏丹的生物信息学:现状与挑战——以苏丹国立大学为例。
PLoS Comput Biol. 2021 Oct 21;17(10):e1009462. doi: 10.1371/journal.pcbi.1009462. eCollection 2021 Oct.
2
A Review of Cancer Genetics and Genomics Studies in Africa.非洲癌症遗传学与基因组学研究综述
Front Oncol. 2021 Feb 15;10:606400. doi: 10.3389/fonc.2020.606400. eCollection 2020.
3
BRCA1 and BRCA2 pathogenic sequence variants in women of African origin or ancestry.非洲裔或有非洲血统的女性中的 BRCA1 和 BRCA2 致病性序列变异。

本文引用的文献

1
Screening of BRCA1/2 Mutations Using Direct Sequencing in Indonesian Familial Breast Cancer Cases.在印度尼西亚家族性乳腺癌病例中使用直接测序法筛查BRCA1/2突变
Asian Pac J Cancer Prev. 2016;17(4):1987-91. doi: 10.7314/apjcp.2016.17.4.1987.
2
Clinical and pathological features of BRCA1/2 tumors in a sample of high-risk Moroccan breast cancer patients.高危摩洛哥乳腺癌患者样本中BRCA1/2肿瘤的临床和病理特征
BMC Res Notes. 2016 Apr 29;9:248. doi: 10.1186/s13104-016-2057-8.
3
Family history predictors of BRCA1/BRCA2 mutation status among Tunisian breast/ovarian cancer families.
Hum Mutat. 2019 Oct;40(10):1781-1796. doi: 10.1002/humu.23804. Epub 2019 Jul 3.
突尼斯乳腺癌/卵巢癌家族中BRCA1/BRCA2突变状态的家族史预测因素
Breast Cancer. 2017 Mar;24(2):238-244. doi: 10.1007/s12282-016-0693-4. Epub 2016 Mar 30.
4
Contribution of BRCA1 and BRCA2 Germline Mutations to Early Algerian Breast Cancer.BRCA1和BRCA2基因种系突变对阿尔及利亚早期乳腺癌的影响
Dis Markers. 2016;2016:7869095. doi: 10.1155/2016/7869095. Epub 2016 Feb 22.
5
Breast cancer in high-risk Afrikaner families: Is BRCA founder mutation testing sufficient?高危阿非利卡人家庭中的乳腺癌:BRCA 始祖突变检测是否足够?
S Afr Med J. 2016 Feb 3;106(3):264-7. doi: 10.7196/SAMJ.2016.v106i3.10285.
6
Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing.在最初10000例接受新一代癌症基因检测的患者中,致病性和可能致病性变异的患病率。
Genet Med. 2016 Aug;18(8):823-32. doi: 10.1038/gim.2015.166. Epub 2015 Dec 17.
7
BRCA1, BRCA2 and PALB2 mutations and CHEK2 c.1100delC in different South African ethnic groups diagnosed with premenopausal and/or triple negative breast cancer.在不同南非种族群体中,患有绝经前和/或三阴性乳腺癌的个体的BRCA1、BRCA2和PALB2基因突变以及CHEK2基因c.1100delC突变
BMC Cancer. 2015 Nov 17;15:912. doi: 10.1186/s12885-015-1913-6.
8
A novel BRCA2 in frame deletion in a Tunisian woman with early onset sporadic breast cancer.一名突尼斯早发性散发性乳腺癌女性患者中发现一种新型的BRCA2框内缺失。
Pathol Biol (Paris). 2015 Sep;63(4-5):185-9. doi: 10.1016/j.patbio.2015.07.009. Epub 2015 Aug 29.
9
Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.BRCA1和BRCA2基因突变的类型及位置与乳腺癌和卵巢癌风险的关联。
JAMA. 2015 Apr 7;313(13):1347-61. doi: 10.1001/jama.2014.5985.
10
A rare truncating BRCA2 variant and genetic susceptibility to upper aerodigestive tract cancer.一种罕见的截短型BRCA2变异体与上呼吸消化道癌症的遗传易感性。
J Natl Cancer Inst. 2015 Apr 2;107(5). doi: 10.1093/jnci/djv037. Print 2015 May.